Delivery Order SPE2DB20D3505-SPE2DB22FU3B8
Award Date 9/14/22
Potential Completion Date 9/15/22
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,310.09, is for the delivery of Olopatadine HCl 0.1% eye drops in 5ml vials. The contract is a delivery order type with a firm fixed price pricing structure, and the ultimate completion date is December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.35 firm fixed price delivery order covers the procurement of OLOPATADINE HCL 0.1% EYE DROPS 5ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
- This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,009.00 for the procurement of Olopatadine HCl 0.1% eye drops in 5 ml containers. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award, which is not designated as a set-aside contract....
- This federal contract award, valued at $2,115.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine Hydrochloride 0.1% eye drops, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $2,112.82 firm-fixed-price contract has a performance period through May 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,825.66 firm fixed price delivery order is for the supply of Olopatadine HCL 0.1% eye drops, a prescription ophthalmic medication. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine HCl 0.1% eye drops. The contract has a ceiling value of $2,252.93 and is a firm fixed price delivery order with a period of performance through March 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
- This federal contract award, valued at $1,911.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4559605390 - Olopatadine HCL 0.1% Eye Drops 5ml. The contract has a firm fixed-price delivery order pricing type and an ultimate completion date of January 17, 2023. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,308.39, is for the delivery of OLOPATADINE HCL 0.1% eye drops in 5ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Olopatadine Hydrochloride 0.1% Eye Drops in 5 mL containers. The award, with a ceiling value of $2,085.00, is a Firm Fixed Price Delivery Order contract with a completion date of August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp.'s Corporate Office Division is the prime contractor for this award, which is part...